Article contents
The Neuroleptic Malignant Syndrome and Pneumomediastinum
Published online by Cambridge University Press: 02 January 2018
Abstract
A patient is described who suffered from the neuroleptic malignant syndrome, complicated by a pneumomediastinum. This has not been reported previously.
- Type
- Brief Reports
- Information
- Copyright
- Copyright © Royal College of Psychiatrists, 1989
References
Abbott, R. J. & Loizou, L. A. (1986) Neuroleptic malignant syndrome. British Journal of Psychiatry, 148, 47–51.CrossRefGoogle ScholarPubMed
Addonizio, G., Susman, V. L. & Roth, S. D. (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry, 143, 1587–1590.Google ScholarPubMed
Addonizio, G., & Susman, V. L. (1987) ECT as a treatment alternative for patients with symptoms of the neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 48, 102–105.Google ScholarPubMed
Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 79–83.Google ScholarPubMed
Delay, J. & Deniker, P. (1968) Drug induced extrapyramidal syndromes. Handbook of Clinical Neurology, vol. 6. Diseases of the Basal Ganglia.
New York: Elsevier.Google Scholar
Dhib-Jalbut, S., Hesselbrock, R., Mouradian, M. M., et al (1987) Bromocriptine treatment of neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 48, 69–73.Google ScholarPubMed
Lavie, C. J. (1986) Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents?
Postgraduate Medicine, 80, 171–178.Google ScholarPubMed
Maunder, R. J., Pierson, D. J. & Hudson, L. D. (1984) Subcutaneous and mediastinal emphysema. Pathophysiology, diagnosis, and management. Archives of Internal Medicine, 144, 1447–1453.CrossRefGoogle ScholarPubMed
Smego, R. A. & Durack, D. T. (1982) The neuroleptic malignant syndrome. Archives of Internal Medicine, 142, 1183–1185.CrossRefGoogle ScholarPubMed
Ward, A., Chaffman, M. O. & Sorkin, E. M. (1986) Dantrolene. A review of its pharmacodynamic, and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs, 32, 130–168.CrossRefGoogle Scholar
- 7
- Cited by
eLetters
No eLetters have been published for this article.